Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) Target Price at $29.11

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $22.44.

A number of equities research analysts have recently weighed in on the stock. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Barclays decreased their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a report on Wednesday. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Wednesday. Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. Finally, Roth Mkm lowered their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th.

Institutional Trading of Aspen Aerogels

A number of large investors have recently bought and sold shares of the business. Abbot Financial Management Inc. increased its stake in Aspen Aerogels by 3.9% in the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company’s stock valued at $359,000 after purchasing an additional 1,146 shares during the period. Franklin Resources Inc. increased its position in Aspen Aerogels by 5.3% in the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after acquiring an additional 1,483 shares during the period. Invesco Ltd. raised its stake in Aspen Aerogels by 3.5% during the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock valued at $604,000 after acquiring an additional 1,724 shares during the last quarter. Greenwood Capital Associates LLC raised its stake in Aspen Aerogels by 5.0% during the 4th quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock valued at $439,000 after acquiring an additional 1,749 shares during the last quarter. Finally, nVerses Capital LLC lifted its position in Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after acquiring an additional 1,800 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 2.0 %

NYSE:ASPN opened at $8.14 on Friday. Aspen Aerogels has a 12-month low of $8.02 and a 12-month high of $33.15. The firm has a market cap of $667.48 million, a PE ratio of 50.85 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a fifty day moving average price of $11.85 and a 200 day moving average price of $18.22.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Sell-side analysts anticipate that Aspen Aerogels will post 0.22 earnings per share for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.